Against that backdrop, Seeking Alpha's Quant Ratings highlight a number of biotechnology companies that currently rank among ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by ...

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core ...

U.S. drug companies are accelerating licensing deals with Chinese pharmaceutical companies to take advantage of China’s ...

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026.

The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the ...

View Anbio Biotechnology Class A NNNN stock quote prices, financial information, real-time forecasts, and company news from CNN.